0.01). Immunoblot analyses confirmed a significant increase in Basic fibroblast growth factor expression is increased in human
FGF-2 protein expression in kidneys with interstitial scarring.
renal fibrogenesis and may mediate autocrine fibroblast prolif-
In situ hybridization studies demonstrated low-level detection eration.
of FGF-2 mRNA in normal kidneys. However, FGF-2 mRNA Background. Interstitial fibroblasts play a critical role in expression was robustly up-regulated in interstitial and tubular renal fibrogenesis, and autocrine proliferation of these cells cells in end-stage kidneys, indicating that these cells are the may account for continuous matrix synthesis. Basic fibroblast source of excess FGF-2 protein. Primary cortical fibroblasts growth factor (FGF-2) is mitogenic for most cells and exerts express FGF-2 and FGFR-1 in vitro. FGF-2 induced a robust intracrine, autocrine, and paracrine effects on epithelial and growth response in these cells that could be blocked specifically mesenchymal cells. The aims of the present studies were to by a neutralizing FGF-2 antibody. Interestingly, the addition localize and quantitate the expression of FGF-2 in normal and of the neutralizing antibody alone did reduce basal proliferation pathologic human kidneys and to study the in vitro effects of up to 31.5%. In addition, FGF-2 induced expression of ␣-smooth FGF-2 on proliferation, differentiation, and matrix production muscle actin up to 1.6-fold, but no significant effect was observed of isolated cortical kidney fibroblasts.
on the synthesis of collagen type I and fibronectin. Finally, Methods. FGF-2 protein expression was localized by immustaining for MIB-1 revealed a good correlation of interstitial nofluoresence double labelings in normal and fibrotic human FGF-2 positivity with interstitial and tubular proliferative activkidneys. Subsequently, interstitial FGF-2 labeling was deterity (r ϭ 0.71, P Ͻ 0.01 for interstitial proliferation, N ϭ 30). mined semiquantitatively in 8 normal kidneys and 39 kidneys
Conclusions. Interstitial FGF-2 protein and mRNA expreswith variable degrees of interstitial fibrosis and was correlated sion correlate with interstitial scarring. FGF-2 is a strong mitowith the morphometrically determined interstitial cortical volgen for cortical kidney fibroblasts and may promote autocrine ume. In addition, FGF-2 expression was quantitated by immufibroblast growth. Expression of FGF-2 correlates with interstinoblot analysis in three normal and six fibrotic kidneys. FGF-2 tial and tubular proliferation in vivo. mRNA was localized by in situ hybridizations. Seven primary cortical fibroblast lines were established, and expression of FGF-2 and FGF receptor-1 (FGFR-1) were examined. The effects of FGF-2 on cell proliferation were determined by bromoFibrosis is a process that is characterized by excessive deoxyuridine incorporation and cell counts, those on differentideposition of matrix components compromising organ ation into myofibroblasts by staining for ␣-smooth muscle actin, function because of replacement of normal organ tissue.
and those on matrix synthesis by enzyme-linked immunosorbent assay for collagen type I and fibronectin. Finally, proliferaTissue fibrosis can affect almost any organ but prefers tive activity in vivo was evaluated by expression of MIB-1 (Ki-67 tissues with common inflammations, such as the skin, antigen). the lung, the liver, and the kidney [1] . Inflammation is
Results. In normal kidneys, FGF-2 expression was confined caused by the recruitment of infiltrating inflammatory to glomerular, vascular, and a few tubular as well as interstitial cells such as lymphocytes and monocytes/macrophages.
fibroblast-like cells. The expression of FGF-2 protein was increased in human kidneys, with tubulointerstitial scarring corInflammatory infiltration is followed by activation and relating with the degree of interstitial fibrosis (r ϭ 0.84, P Ͻ proliferation of matrix-producing cells, mainly fibroblasts, which synthesize excessive amounts of extracellular matrix. Cytokines seem to play a decisive role in fibroblasts deposit matrix in an organized fashion, similar remains controversial. Recently, Floege et al analyzed FGF-2 expression in normal human kidneys using four to normal skin in fetal wounds, adult wounds are characterized by the deposition of disorganized collagen fibers different antibodies, and localized it most consistently to distal tubular epithelial and vascular smooth muscle [3] . Studies by Whitby and Ferguson have demonstrated that the differential expression of certain cytokines is cells [18] . FGF-2 is mitogenic for mesangial [19] , proximal-tubular epithelial [20] , glomerular endothelial [21] , one of the key reasons for scar formation. Transforming growth factor-␤ (TGF-␤) immunostaining, for example, and glomerular epithelial cells [15] . Floege et al demonstrated that FGF-2 was synthesized by mesangial cells was absent in fetal mouse wounds and was abundant in neonatal and adult mouse wounds [4] . Another cytokine in vitro and in vivo [14] . Furthermore, FGF-2 infusions into rats injected with an antimesangial cell antibody that was markedly up-regulated in postnatal wounds with fibrosis was basic fibroblast growth factor (FGF-2). Whitby (anti-Thy 1.1) resulted in a fourfold increase in glomerular cell proliferation [22] and led to increased podocyte and Ferguson demonstrated that, similar to TGF-␤, FGF-2 is present in neonatal and adult mouse lips but injury and glomerulosclerosis in rats with membranous nephropathy [23] . Similarly, treatment of rats for 8 and cannot be detected in fetal mouse lip wounds [4] . Thus, similar to TGF-␤, FGF-2 may play an important role in 13 weeks with subcutaneous FGF-2 injections resulted in focal segmental glomerulosclerosis, with an increase the scarring process.
In the kidney, chronic tubulointerstitial fibrosis is the of the peritubular interstitium [24] . Finally, Ray et al studied a transgenic mouse model of HIV-associated final common pathway of glomerular, vascular, or interstitial inflammations, often resulting in end-stage renal nephropathy and described increased interstitial staining for FGF-2 colocalized with extracellular matrix [25] . disease [5] . The severity of chronic tubulointerstitial disease is the single best histologic correlate of the decline
The aims of the present study were the evaluation of FGF-2 expression in normal and fibrotic human kidneys in renal function and prognosis for organ function [1, 6] . As in other scarring processes, a number of cytokines and its potential role in renal fibrogenesis. have been implicated in renal fibrogenesis, including platelet-derived growth factor (PDGF) and TGF-␤. PDGF is METHODS a strong mitogen for some but not all fibroblasts [7] , and Materials PDGF-BB has been shown to cause interstitial cell proliferation, the appearance of myofibroblasts, and kidney Rabbit polyclonal antibody to FGF-2 (Ab-2) and mouse monoclonal antibody to FGF receptor-1 (FGFR-1) were fibrosis in rats if given intravenously in high doses [8] . TGF-␤ affects all phases of wound healing, including the purchased from Calbiochem (La Jolla, CA, USA). Human recombinant FGF-1 and FGF-2 were from R&D inflammatory response and matrix accumulation [9, 10] . Increased expression of TGF-␤1 has been described in a Systems (Minneapolis, MN, USA), as was the neutralizing goat polyclonal antibody to FGF-2. Mouse monovariety of animal models and human diseases associated with renal fibrosis [reviewed in 1]. However, the role of clonal antibody to collagen type I was obtained from Southern Biotechnology (Birmingham, AL, USA). Polyother cytokines, such as FGF-2, is less well defined. FGF-2 belongs to the family of fibroblast growth and clonal rabbit antibody to fibronectin antibody was purchased from Sigma (St. Louis, MO, USA), and mouse differentiation factors that currently contains nine members [11] . Up-regulated expression of FGF-2 has been monoclonal antibody to heparan sulfate was from Boehringer Mannheim (Mannheim, Germany). For cell charlinked to fibrogenesis in a number of animal models. Injection of FGF-2 into subcutaneous tissue of newborn acterization, the following additional mouse monoclonal antibodies were used: anticytokeratin (Dako, Carpinmice caused slight fibrotic changes after seven days of injection, whereas simultaneous application with TGF-␤ teria, CA, USA), antivimentin (Boehringer Mannheim), anti-factor VIII (Dako), anti-human lymphocyte antiresulted in persistent skin fibrosis [12] . Moreover, FGF-2 is a strong mitogen for pulmonary fibroblasts and hepatic gen-DR (HLA-DR) (Dako), anti-␣-smooth muscle actin (PaeselϩLorei, Wiesbaden, Germany), anticollagen stellate cells, and has thus been implicated in the pathogenesis of lung and liver fibrosis, although the exact role type III (Southern Biotechnology), anti-CD 44 (Pharmingen, San Diego, CA, USA), anti-CD 54, and anti-CD remains to be elucidated.
Regarding the kidney, FGF-2 protein was isolated 68 (Dako). The mouse monoclonal antibody to collagen type IV was a generous gift from Steven Gay (University from whole kidney homogenates as early as 1985 [13] . Floege et al, as well as Takeuchi et al, reported strong of Zü rich, Zü rich, Switzerland). Trypsin-ethylenediaminetetraacetic acid (EDTA), Dulbecco's modified Eagle's immunostaining in Bowman's capsule, the glomerular mesangium, blood vessels, and the interstitium, as well as medium (DMEM), Iscove's modified Dulbecco's medium, and fetal calf serum (FCS) were obtained from within some tubules in rats [14, 15] , although their results could not be confirmed by all investigators [16, 17] and GIBCO BRL Ltd. (Paisley, Scotland). Cell culture dishes were from Becton Dickinson (Franklin Lakes, NJ, USA). the exact localization of FGF-2 protein in the kidney
Patient material
formaldehyde using 1 ϫ MOPS, pH 7.0, as the running buffer. Photographs of ethidium-bromide-stained gels Kidney tissues from 39 patients with primary and secwere taken under ultraviolet illumination. RNA was subondary renal diseases and a variable degree of tubuloinsequently transferred to a nylon membrane (Hybond N; terstitial fibrosis were used in this study. Tissues included Amersham, Arlington Heights, IL, USA) by capillary 32 biopsies and 7 nephrectomy specimens. The nephrectransfer for 12 hours with 20 ϫ standard saline citrate tomies were performed in patients with end-stage renal (SSC) as the transfer buffer. Blots were baked at 80ЊC disease caused by intractable hypertension or recurrent and prehybridized for one hour at 68ЊC in prehybridizaurinary tract infections. The use of parts of nephrectomy tion solution containing 0.5 mol/L Na 2 HPO 4 buffer (pH specimens or kidney biopsies for research purposes was 7.2), 0.5 mol/L EDTA (pH 8.0), 25% sodium dodecyl approved by the ethics committee of the Georg-Augustsulfate (SDS), and 1.5% blocking reagent. FGF-2 specific University, and written consent was obtained from all oligonucleotides (R&D Systems) were labeled with dipatients prior to nephrectomy or kidney biopsy. Normalgoxigenin using a kit (Boehringer Mannheim) according appearing kidney tissue from kidneys that proved either to the manufacturer's instructions. Hybridizations were unsuitable for transplantation or were explanted because performed overnight at 58ЊC using the prehybridization of tumor nephrectomies were used as controls (N ϭ 8) .
solution. Tk 188 fibroblasts were obtained by lysis with a deter-(100 U/mL). For the isolation of primary human renal gent-based buffer containing 0.4% sodium deoxycholate, fibroblasts, cortical parts of renal biopsy cylinders or ne-1% NP-40, 1.9% EGTA, and 10 mmol/L Tris (pH 7.4). phrectomy specimens were cut and emerged in DMEM One hundred micrograms of total cellular protein and medium with 20% FCS and penicillin/streptomycin in 50 ng FGF-2 control protein were run on an 18% SDSthe previously mentioned concentrations. When cells had polyacrylamide electrophoresis gel and transferred to a grown to confluence, they were characterized by immunonitrocellulose membran (Hybond ECL; Amersham) fluorescence for cytokeratin, vimentin, ␣-smooth muscle by electroblotting. Membranes were stained with Ponactin, collagen types I, III, IV, factor VIII, CD 68, and ceau red to control for adequate transfer and equally HLA-DR. Cells that were positive for vimentin and at loaded amounts. After blocking, the membrane was inleast collagen types I and III, and negative for cytokeracubated with the respective antibody (anti-FGF-2 in a tin, factor VIII and HLA class II were considered to be concentration of 1:40) followed by the secondary antifibroblasts and were used for induction assays in passages 2 body (donkey-antirabbit, horseradish peroxidase-linked, through 8. For detection of heparan sulfate proteoglycane concentration 1:3000; Amersham). Positive reaction proexpression, fluorescence activated cell sorting (FACS) ducts were identified by enhanced chemiluminescence analysis was performed as described previously [26] .
(ECL; Amersham) according to the manufacturer's protocol.
Specificity of the basic fibroblast growth factor antibody
Immunhistochemical staining for basic fibroblast growth factor and morphometric evaluation of To determine the specificity of the applied antibody, interstitial volume FGF-2 expression in Tk 173 and Tk 188 fibroblasts (which are easier to culture than primary fibroblasts) was first Tissue from normal human kidneys, renal biopsies, analyzed by immunocytochemistry as described preand end-stage kidneys were snap frozen in liquid nitroviously, using the anti-FGF-2 and the secondary FITCgen. Sections of 4 to 6 m were cut, mounted on microantirabbit antibodies at concentrations of 1:20 [27]. For scope slides, and fixed in ice-cold acetone for 10 minutes. Northern blot analyses, total cellular RNA was extracted Sections were then allowed to dry, and unspecific binding from cultured cells using RNA-clean (AGS, Heidelwas blocked by incubation with goat serum. Anti-FGF-2 berg, Germany) according to the manufacturer's instrucantibody was added in a concentration of 1:20. After tions. Concentration of RNA was determined by abincubation for 60 minutes and several washes in phossorbance at 260 nm, and samples were stored at Ϫ80ЊC phate-buffered saline (PBS), FITC-antirabbit was added prior to use. Northern blot analysis was performed as in a concentration of 1:20. Positivity was evaluated with described [28] . Briefly, 40 g of total RNA were electroan Axiophot S100 microscope (Zeiss, Jena, Germany). Interstitial cortical staining for FGF-2 was rated by two phoresed on a 1.0% agarose gel containing 2.2 mol/L blinded investigators as in normal kidneys (ϩ), increased Piscataway, NJ, USA). The vector was linearized with the appropriate enzyme, and FGF-2 sense/antisense ri-(ϩϩ), robustly increased (ϩϩϩ), or absent (Ϫ). Negative controls consisted in substitution of the primary antiboprobes were synthesized and labeled with digoxigenin by in vitro transcription with the DIG RNA labeling body with an irrelevant rabbit polyclonal antibody or PBS.
In selected sections, double labelings were performed kit (Boehringer Mannheim) as described [31] . Tissue sections were mounted on Sectionlock slides (Polyto characterize FGF-2-positive interstitial cells. In that case, an addition of the anti-FGF-2 antibody was followed sciences, Eppelheim, Germany), briefly heated to 50ЊC to ensure fixation, dried for 30 minutes, and fixed in 3% by staining for ␣-smooth muscle actin, vimentin, cytokeratin, HLA-DR, CD 44, CD 54, and CD 68. FITC-antiparaformaldehyde for 7 minutes. Washing in PBS and 2 ϫ SSC was followed by prehybridization for 60 minutes rabbit and the appropriate rhodamin-labeled antibody were added sequentially at a concentration of 1:20. Phoat 43ЊC in hybridization buffer (Amersham) containing 50% formamide (Sigma). Hybridization was then pertographs were taken either by double or by sequential exposure using Zeiss camera and software (MC 200 Chip).
formed in 40 to 60 L hybridization buffer per section containing the cRNA probe at a concentration of 200 Selected sections from normal and fibrotic kidneys were also paraffin embedded after fixation in formaldeng/mL, followed by washing in 2 ϫ SSC for 5 minutes at 37ЊC and twice for 15 minutes in 0.1 ϫ SSC, SDS at hyde using a standard avidin-biotin complex (ABC) method, as described previously [27] .
68ЊC. After a final wash in 100 mmol/L Tris-HCl and 150 mmol/L NaCl for five minutes at room temperature, For morphometric evaluation, all tissue specimens were fixed in 4% buffered formalin solution (pH 7.4) 1% blocking buffer and 10% goat serum (Dako) were added, and the sections were incubated with a 1:500 and embedded in paraffin. Tissue sections were stained for trichrome or PAS, and point counting was performed dilution of alkaline-phosphatase conjugated anti-DIG antibody for two hours at room temperature. Detection as described by Bohle et al [29] . Only those specimens containing at least five glomeruli were evaluated. Five was performed after several washes in 100 mmol/L TrisHCl, 150 mmol/L NaCl with detection buffer containprojection fields of the cortex were examined per kidney using a lattice of 1 cm at a magnification of ϫ250, discriming 0.18 mg/mL 5-bromo-4-chloro-3-indolyl-phosphate (BCIP), 0.34 mg/mL nitro blue tetrazolium (NBT), and inating between interstitium, tubular epithelia, glomeruli, and vasculature. Big blood vessels were ignored. The 240 g/mL levamisole. After 12 hours, color reaction was stopped by washing in 10 mmol/L Tris (pH 8) and value for the interstitium was expressed as a percentage of the analyzed cortex.
1 mmol/L EDTA for five minutes, and coverslips were mounted. Sections from human synovia, which is known Quantitation of basic fibroblast growth to express FGF-2 abundantly, served as positive control. factor expression Proliferation assay Expression of FGF-2 protein was quantitated by immunoblot analysis. Briefly, lysates were obtained from Proliferation studies in primary cortical fibroblasts were performed using nonradioactive bromodeoxyurisix kidneys with considerable interstitial scarring and three control kidneys. Immunoblots were performed as dine incorporation assays (Amersham) based on the method by Gratzner [32] . Four ϫ 10 3 cells were plated described earlier in this article using 100 g of protein and 50 ng of FGF-2 recombinant protein as positive per well in 96-well microtiter plates containing DMEM medium with the usual supplements and incubated overcontrol. After staining for Ponceau red, blots were analyzed densitometrically for later normalization. Positive night to allow cell attachment. Cells were then made quiescent by replacement of DMEM medium with Isreaction products were again identified by chemiluminescence using a Fluor-S Multiimager (Bio-Rad, Hercove's medium and subsequent incubation for 24 hours.
In preliminary experiments, cytokines were added, and cules, CA, USA), and densitometric analysis was performed with Multi-Analyst software (Bio-Rad).
proliferation was measured after 24, 48, 72, and 96 hours. FGF-2 was used in concentrations of 0.1, 1, 10, Vector assembly and in situ hybridization for basic and 100 ng/mL (equivalent to 5.5 ϫ 10 Ϫ12 mol/L, 5.5 ϫ fibroblast growth factor 10 Ϫ11 mol/L, 5.5 ϫ 10 Ϫ10 mol/L, and 5.5 ϫ 10 Ϫ9 mol/L, respectively). In a second set of experiments, 1 ng/mL In situ hybridizations were performed on 6 m sections of snap-frozen tissue from freshly explanted kid-FGF-2 was added, and bromodeoxyuridine incorporation was measured after 72 hours. The specificity of the neys using a digoxigenin-labeled cRNA probe. FGF-2 cDNA was purchased from R&D Systems, digested with response to FGF-2 was determined by addition of a neutralizing FGF-2 antibody in a concentration of 10 g/mL Hind III and BamHI, and cloned into pBS SK II (Stratagene, La Jolla, CA, USA) as described [30] . The new (which had been determined in titration experiments with Tk 173 fibroblasts) or a nonrelevant IgG. Both vector was named FGF-2-pBS. Correct ligation was verified by sequence analysis using Alf-Express (Pharmacia, antibodies were also added without FGF-2 to study their intrinsic effects on proliferation. Medium was changed to determined microscopically using an Axiophot S100 microscope (Zeiss) by a blinded investigator, and the perIscove's containing BrdU/FdU in a dilution of 1:500 four hours prior to measurements. Cells were then washed centage of ␣-smooth muscle actin-positive cells was calculated. Each experiment was repeated three times three times in PBS and fixed in methanol containing 2% hydrogen peroxide followed by denaturation in 1N HCl independently. for 10 minutes. After a further three times of washing Matrix synthesis in PBS containing 0.1% Tween and blocking for 30 minutes in PBS (0.1% Tween, 3% BSA), 50 L of anti-BrdU Enzyme-linked immunosorbent assay (ELISA) of supernatants were performed as described [33] , with some antibody were added and incubated for 45 minutes. Cells were again washed three times in PBS/Tween, and peroxmodifications, including the use of chemiluminescence to enhance sensitivity [34] . Eight ϫ 10 3 cells were plated idase substrate was added (100 L/well). Optical densities were subsequently determined photometrically at per well, and cells were again made quiescent by incubation in serum-free medium for 24 hours. Next, FGF-2 405 nm (Dynatech MR 4000; Dynatech, Denkendorf, Germany). All experiments were performed in triplicate was added in concentrations of 0.1, 1.0, and 10 ng/mL followed by incubation for 48 hours. Human recombiand repeated five times. Results are shown in percentage of negative control (Iscove's medium ϭ 100%).
nant TGF-␤1 (R&D Systems) in a concentration of 1 ng/mL served as a positive control. Fifty g/mL ascorbic In a third set of experiments, confluent monolayers of fibroblasts were trypsinized, and cells were seeded at 4 ϫ acid and 50 g/mL propionitrile (both from Sigma) were added in experiments evaluating collagen synthesis. Su-10 3 cells per well in 96-well culture plates. After 12 hours, DMEM medium was replaced by Iscove's medium. After pernatants were transferred to a Maxisorp plate and incubated overnight at room temperature. Plates were a further 24 hours, cells were incubated with various factors (FGF-2 at concentrations of 0.1, 1, 10, and 100 subsequently dried for two hours and blocked with 3% dried milk. Incubation with 50 L of the primary anting/mL, FGF-2 (1 ng/mL) ϩ FGF-neutralizing antibody (10 g/mL), FGF-2 (10 ng/mL) ϩ irrelevant IgG, and body (anticollagen type I was used in a concentration of 1:300 and antifibronectin at 1:5000) was followed by FGF-2 (1 ng/mL) ϩ heparin (10 g/mL) for 72 hours before cell counts were performed. PDGF-BB at 10 washing two times with PBS/0.1% Tween and incubation with the secondary antibody [antimouse-IgG-AP and ng/mL and heparin alone (10 g/mL) served as controls. Again, all experiments were performed in triplicate and antirabbit-IgG-AP (both Boehringer Mannheim, Germany), both used at a concentration of 1:1000]. After repeated five times. two additional wash steps, 100 L of CSPD-Ready-toImmunofluorescence staining of ␣-smooth Use substrate (Boehringer Mannheim) were added, and muscle actin quantitation was performed in a luminometer (Mikrolumat CB 96P; Berthold, Bad Wildbad, Germany) using The effects of FGF-2 on the differentiation of kidney fibroblasts into myofibroblasts were assessed by immuMikroWin software (Mikrotek, Overath, Germany). Nonspecific binding was determined by incubation with nofluorescent staining of ␣-smooth muscle actin after continuous exposure to FGF-2 for 48 hours. Cells were the secondary antibody only. The value was normally less than 5% of the total chemiluminescence and was seeded in microchamber slides and incubated in regular medium for 12 hours. After 24 hours of incubation in subtracted from each assay. All assays were performed in triplicate and repeated five times. Standardization was Iscove's medium for quiescence, FGF-2 was added in concentrations of 0.1, 1.0, and 10 ng/mL. At the end of obtained for the collagen type I ELISA using human type I collagen (Becton Dickinson, Bedford, MA, USA). incubation, cells were washed twice with PBS and fixed with ethanol/acetic acid (50:50, vol/vol) for 20 minutes
The limit of detection was 1 ng/mL, with a working range of 10 to 1000 ng/mL. Human fibronectin (Sigma) served at 4ЊC. The cells were subsequently washed again and incubated for two hours at room temperature with a as standard for the fibronectin ELISA. The working range of that ELISA was 0.1 to 10 g/mL, with a limit 1:200 dilution of a monoclonal mouse antibody to human ␣-actin isoform of smooth muscle cells. Cells were then of detection of 10 ng/mL. All values were corrected for cell counts (10 3 cells), which were performed after transwashed again with PBS and incubated for 60 minutes at room temperature with the FITC-conjugated rabbitfer of supernatants. antimouse antibody. Control cultures were incubated Evaluation of cell proliferation in vivo without application of the primary antibody. Incubation with TGF-␤1 (1 ng/mL) served as a positive control.
Immunostaining with MIB-1 (Dako) was used to evaluate cell proliferation in vivo. Five-micrometer thick secCells with the typical ␣-actin structure were considered to be ␣-actin positive. Additional staining with the tions were cut, dewaxed, and rehydrated according to routine procedures. Sections were pretreated in a microHoechst dye H33258 to identify nuclei was performed to facilitate cell counting. For each group, 500 cells were wave oven for 5 minutes and then incubated for 60 min-utes at room temperature with the MIB-1 antibody, which was used in a concentration of 1:50. The streptavidinbiotin/alkaline phosphatase complex technique (Dako) was performed, and Fast Red was used as the chromogen. The sections were counterstained with hematoxylin. All stained nuclei were rated as positive. Proliferative activity within the interstitium and tubular epithelium was quantitated separately by counting MIB-1-positive cells in four fields at ϫ250 magnification using an integration grid.
Statistical analysis
All values are expressed as mean Ϯ SEM unless specified. Analysis of variance (ANOVA) was used to determine statistical differences between growth factortreated groups and controls using Sigma-Stat software (Jandel Scientific, San Rafael, CA, USA). Further analysis was carried out using Bonferroni's test to control for multiple testing. For nonnormally distributed data (MIB-1 staining), the Mann-Whitney rank sum test was applied. A correlation between semiquantitative interstitial FGF-2 staining, morphometric volume, and MIB-1 positivity was evaluated by Spearman's rank-order correlation coefficient. P values Ͻ 0.05 were considered significant.
RESULTS

Specificity of the anti-basic fibroblast growth factor antibody
Since the exact localization of FGF-2 in the kidney is still controversial, we first determined the specificity of the antibody used for our studies. First, immunofluores- body detects a specific 18 kd band in the two fibroblast lines corresponding to the size of the recombinant protein (Fig. 1B) . The two additional bands found mainly in Tk 173 fibroblasts probably correspond to multiple nica media of blood vessels, few tubular (mainly distal by morphology), and many, albeit not all, interstitial cells translation initiation sites [35] . There was no cross-reactivity of the antibody with FGF-1 (acidic fibroblast (Fig. 2) . The number of positive interstitial cells was considerably smaller in paraffin sections, probably begrowth factor; data not shown).
cause of differences in antigen stability (data not shown).
Basic fibroblast growth factor expression is expressed
To further characterize the FGF-2-positive cells within in interstitial fibroblast-like cells and increased in the interstitium, immunofluorescent double labelings kidneys with tubulointerstitial fibrosis were performed in normal kidneys and biopsies from kidneys with minimal interstitial involvement (interstiBasic fibroblast growth factor expression was first analyzed in frozen sections of normal kidneys by indirect tium morphometrically Ͻ25%). The results are depicted in Figure 2 . Most of the FGF-2-positive cells within the immunofluorescence. Immunolabeling of normal kidneys demonstrated FGF-2 protein within glomeruli, tuinterstitium stained also positive for CD 54 (intercellular There is marked coexpression for FGF-2 and all three markers of interstitial fibroblasts; however, again, the overlap in staining is not complete. Some interstitial cells label exclusively for FGF-2 and some exclusively for ␣-smooth muscle actin (C and D). Original magnification ϫ400 (A and B) and ϫ200 (C, D, E and F).
adhesion molecule-1; Fig. 2E ) and CD 44 ( Fig. 2F) , alout significant interstitial scarring (numbers 14, 15, 33, though many FGF-2-positive cells did not label for both. and 34). No increase in FGF-2 expression was observed In addition, almost all FGF-2-positive cells did stain for in any of the four specimens. Thus, when FGF-2 protein vimentin as well (data not shown). There was a considexpression was correlated with the interstitial volume erable overlap in interstitial staining for FGF-2 and only in those kidneys in which widening of the interstitial ␣-smooth muscle actin (Fig. 2C) ; however, there were space was due to scarring, we found an even better corresome cells that expressed ␣-smooth muscle actin but lation (r ϭ 0.84, P Ͻ 0.01). Figure 4 illustrates the correlanot FGF-2. There was some coexpression of FGF-2 and tion graphically. HLA-DR ( Fig. 2A) , but most FGF-2-positive interstitial When the specimens from patients with glomerulonecells were negative for the HLA class II molecule, which phritis (N ϭ 20) were analyzed exclusively, the correlais expressed on dendritic cells and macrophages. Only tion was still significant (r ϭ 0.65, r Ͻ 0.01). The number occasionally was coexpression of FGF-2 and the macroof individual diseases was too small to analyze them phage marker CD 68 observed (Fig. 2B) , indicating that separately. However, looking at the specimens with IgA only very few FGF-2-positive cells are macrophages.
nephritis, there may be a biphasic expression pattern of Judging by the difference in staining for CD 68 and FGF-2 with a ϩϩϩ expression at interstitial volumes of HLA-DR, some of the cells that stained for FGF-2 may 37 to 46% and a ϩϩ expression at volumes of 55 to be dendritic cells, but the majority clearly are not. CD 44, 71%. There was no correlation between interstitial CD 54, and ␣-smooth muscle actin have all been propa-FGF-2 staining and interstitial volume in the specimens gated as potential markers of fibroblasts [36, 37] . Thus, from patients with tubulointerstitial nephritis. it seems reasonable to assume that most FGF-2-positive cells within the interstitium are probably fibroblasts or FGF-2 protein expression is increased in cortical tissue fibroblast-like cells.
from kidneys with interstitial fibrosis We next compared the sections from eight normal Although our immunofluorescence labeling studies renal tissues (from 3 female and 5 male patients, mean had shown a good correlation between interstitial volage 56.9 years) and 39 kidneys (from 12 female and 27 ume and interstitial FGF-2 labeling, we wanted to conmale patients, mean age 45.0 years), each with varying firm this finding by immunoblot analysis. Thus, protein degrees of tubulointerstitial fibrosis. Since we were parwas isolated from cortical tissue from three normal kidticularly interested in the correlation between FGF-2 neys and six kidneys with marked interstitial scarring expression and the degree of interstitial scarring, a vari-[from patients 10 (that is, FK1), 11 (FK2), 13 (FK3), 18 ety of renal diseases was examined. Table 1 (Fig. 5A) . Figure 5B summamorphometric analysis. In normal kidneys, the relative rizes the result after densitometric analysis (P ϭ 0.048). percentage of the interstitium varied between 15 and 25%. Conversely, in the nephrectomy specimens from
In situ hybridizations reveal increased FGF-2 mRNA patients with renal disease, the interstitium occupied beexpression within the tubulointerstitium in tween 49 and 72%. No change of FGF-2 expression was end-stage kidneys observed in normal human kidneys. However, robust
In situ hybridizations were performed to localize FGFup-regulation of FGF-2 expression was noted in kidneys 2-synthesizing cells in three normal and three end-stage with interstitial scarring. Table 1 summarizes the results. kidneys with interstitial fibrosis, tubular atrophy, and Figure 3 depicts the staining results in a kidney with dilation. As expected, hybridization with the sense probe marked interstitial fibrosis. FGF-2-positive cells (Fig. 3 gave no signal (Fig. 6A) . Conversely, hybridization with A, C, and E) also stained positive for vimentin (Fig. 3B) , the antisense probe demonstrated weak staining within ␣-smooth muscle actin (Fig. 3D) , and CD 44 (Fig. 3F) .
glomeruli and blood vessels, as well as occasional tubular Again, there was only little co-staining for the dendritic and interstitial cells in normal kidneys (Fig. 6B ), indicell and macrophage marker HLA-DR and only occacating that these cells synthesize FGF-2 themselves. sional co-staining for the macrophage marker CD 68 Furthermore, similar to what was observed by immuno-(data not shown), excluding prominent expression in fluorescent staining, in situ hybridizations of fibrotic endthese cells. In paraffin-embedded sections, there was an stage kidneys revealed a robust increase in signal for accentuation of extracellular matrix staining, including FGF-2 mRNA within interstitial cells (Fig. 6 C, D) . The tubular basement membrane, whereas fewer cellular elemajority of interstitial cells displayed FGF-2 mRNA poments were labeled.
sitivity. There was also increased staining in tubular cells, When the expression of FGF-2 was correlated with even in some tubules that were dilated and atrophic. the cortical interstitial volume, we found a good correlaConversely, there was no increased FGF-2 mRNA syntion (r ϭ 0.64, P Ͻ 0.01). However, four of the biopsy thesis within the glomeruli of the analyzed kidneys, indispecimens displayed an enlargement of the interstitial volume caused exclusively by interstitial infiltration withcating that most FGF-2 is, in fact, synthesized in nonglo- There were 6 cases of end-stage renal disease (ESRD), 4 cases of acute tubulointerstitial nephritis (TIN), 4 cases of rapidly progressive glomerulonephritis (RPGN), 7 cases of IgA nephropathy, 4 cases of membranous glomerulonephritis (MGN), 5 cases of focal segmental glomerulosclerosis (FSGS), 3 cases of chronic transplant rejection, 2 cases of amyloidosis, 2 cases of diabetic nephropathy, and 2 cases of chronic renal failure of unknown origin (CRF). Eight normal kidneys served as controls. Interstitial FGF-2 labeling was determined semiquantitatively, and interstitial volume determined morphometrically. Interstitial FGF-2 staining was rated as in normal kidneys (ϩ), increased (ϩϩ), or robustly increased (ϩϩϩ). merular cells. Thus, we conclude that the results of the low-affinity receptors were examined in seven primary cortical fibroblast lines. All cell lines were characterized in situ hybridizations parallel the protein stainings, demas fibroblasts and synthesized extracellular matrix comonstrating that increased FGF-2 mRNA synthesis takes ponents, including collagen types I and III, as well as place in interstitial cells within the kidney and that infibronectin. Expression of FGFR-1, one of four highcreased protein detection is not due to mere accumulaaffinity receptors, was analyzed by immunoblot analysis. tion of extrarenally synthesized FGF-2.
The immunoblot analysis demonstrated a double band Detection of FGF-2 expression and its low-and highat approximately 120 kD in all seven fibroblast lines affinity receptors in human primary cortical fibroblasts (Fig. 7A) . The most robust expression of FGFR-1 was observed in fibroblasts isolated from kidneys 25, 31, and To evaluate the possible role of FGF-2 in human renal fibrogenesis, the expression of FGF-2 and its high-and 39, with interstitial volumes of 41, 74, and 79%, respec- tively. In addition, FACS analyses confirmed the expression of heparan sulfate proteoglycane, which serves as a low-affinity receptor for FGF-2 in all seven cell lines. There was no difference in the level of expression (data not shown). kidney from which the cells were isolated. Whereas F33 and F34, isolated from patients 33 and 34 with tubulointerstitial nephritis and no interstitial scarring, displayed relatively moderate positivity for FGF-2, the level of (187.8 Ϯ 8.9%) at a concentration of 1 ng/mL. The maxiexpression was much higher in the fibroblasts isolated mum increase was seen with a concentration of 10 ng/mL from kidneys with interstitial scarring. In addition, there after 72 hours (267.3 Ϯ 24.9%). Figure 8 summarizes the was a good correlation between the relative level of findings obtained with bromodeoxyuridine incorpora-FGF-2 protein expression in the seven fibroblast lines tion after stimulation with FGF-2 at a concentration of and the semiquantitative FGF-2 immunofluorescence la-1 ng/mL for 72 hours in three of the five fibroblast lines. beling in the kidneys from which the cells were isolated F25 and F26 were isolated from biopsies of patients 25 (r ϭ 0.76, P ϭ 0.038).
and 26, displaying increased interstitial volumes because of fibrosis of 41 and 42%, respectively. Conversely, F34 FGF-2 is a strong mitogen for renal fibroblasts, originated from patient 34 with tubulointerstitial nephriinduces differentiation into myofibroblasts, and has no tis and no interstitial scarring. Bromodeoxyuridine incormajor effect on matrix protein synthesis poration was increased between 166.3 Ϯ 3.2% in F34 To evaluate the function of FGF-2, proliferation, difcells and 247.0 Ϯ 15.4% in F26 fibroblasts. This increase ferentiation into myofibroblasts, and matrix protein syncould be specifically inhibited by addition of a neutralizthesis of human renal fibroblasts were examined in five ing antibody to FGF-2, whereas a nonrelevant IgG did different primary cortical fibroblast lines. In a first set not have an effect on FGF-2-induced proliferation. Inof experiments, performed in F25 fibroblasts, FGF-2 terestingly, the addition of the FGF-2 neutralizing anticaused a robust induction of proliferation, which was body alone did decrease bromodeoxyuridine incorporatime and dose dependent. The increase of bromodeoxytion in all five fibroblast lines. However, because of the low level of basal proliferative activity, that decrease was uridine incorporation was significant after 48 hours statistically significant in only three cell lines (maximum cle actin, which serves as a marker for myofibroblast formation. In two primary cortical fibroblast lines, F6 inhibition 31.5% in F25 cells). Conversely, the addition of the nonrelevant IgG resulted in either no change or isolated from a kidney with mild interstitial scarring (interstitial volume 38%) and F39 from a kidney with an an increase in bromodeoxyuridine uptake. In a third set of proliferation experiments, bromodeoxyuridine incorinterstitial volume of 71%, FGF-2 resulted in a timeand dose-dependent induction of ␣-smooth muscle actin poration essays were confirmed by cell counting. In these experiments, cell numbers increased dose dependently expression. Figure 9 summarizes the results observed after 72 hours. The increase was similar to that obtained to a maximal 234.3 Ϯ 15.8% (P Ͻ 0.01) in F25 and to 197.4 Ϯ 18.6% (P Ͻ 0.01) in F34 fibroblasts after 96 hours with TGF-␤1 (increase of ␣-smooth muscle actin-positive cells from 52.3 Ϯ 3.3 to 82.3 Ϯ 1.9% after 72 hours of of incubation at a concentration of 10 ng/mL. Again, the higher concentration (100 ng/mL) did not have any incubation with 1 ng/mL FGF-2; P Ͻ 0.01). Of course, we do not know if these changes were due to de novo superior effect to the 10 ng/mL concentration. There was no additional effect of heparin, which by itself caused a expression of ␣-smooth muscle actin or due to clonal selection of positive cells caused by cell population heterslight reduction in proliferation (maximum inhibition of 18.9 Ϯ 4.5%; NS).
ogeneity. Finally, the influence of FGF-2 on extracellular matrix Activation of fibroblasts into so-called myofibroblasts represents a key step in renal fibrogenesis. We evaluated synthesis was evaluated by ELISAs for collagen type I and fibronectin in F6 and F39 fibroblasts. Whereas the effects of FGF-2 on the expression of ␣-smooth mus- (F24, F31, and F39 ). There was a good correlation between the degree of interstitial scarring and the expression of FGF-2, however, no such correlation could be found regarding the expression of FGFR-1 (discussed in the Results section).
TGF-␤1 (at a concentration of 1 ng/mL) increased secretion of collagen type I (from 101.0 Ϯ 9.8 ng/10 3 cells to interstitial and tubular MIB-1 staining After having established that FGF-2 is a mitogen for human cortical kidney fibroblasts in vitro, we tried to determine whether increased FGF-2 expression was corFifteen patient specimens could not be analyzed because of the lack of tissue that had been used up for other related with increased proliferative activity in vivo. Thus, we stained for expression of the Ki-67 antigen, which is purposes (specimens from patients 5, 7, 14 through 17, 21, 23, 27, 29, 30, 32, and 35 through 37). In normal associated with cell proliferation using the MIB-1 antibody. We were able to perform stainings for MIB-1 in kidneys, only few interstitial and tubular cells displayed MIB-1 positivity (median 1.5 in both; Fig. 10A ), whereas cortical tissue from 24 patients and 8 normal controls. the number of MIB-1-positive cells was considerably 11). There does not seem to be a correlation of FGF-2 staining with acute inflammatory processes, although the higher in patient specimens (median 13.5, P ϭ 0.001 in number of tissues studied is too limited in that regard. interstitial, median 9.0, P ϭ 0.008 in tubular cells; Fig.  10 B-D) . The highest number of MIB-1-positive cells within the interstitium was observed in the two biopsies DISCUSSION from patients with tubulointerstitial nephritis (numbers Virtually all forms of chronic progressive renal disease 33 and 34), which is not surprising given the high proliferare accompanied by changes in the tubulointerstitium, ative activity of infiltrating monocytes/macrophages and irrespective of the primary renal disease [38] . This is not lymphocytes. When the number of MIB-1-positive cells surprising since renal tubules, interstitium, and vasculawas correlated with the semiquantitative FGF-2 staining, ture comprise more than 80% of the renal cortex [39] . there was a positive correlation with the number of interTubulointerstitial changes consist of interstitial inflamstitial (r ϭ 0.48, P Ͻ 0.01) and tubular (r ϭ 0.53, P Ͻ mation followed by fibrosis, tubular atrophy, and dila-0.01) positive cells. However, the correlation was much tion. Along with glomerular scarring, interstitial fibrosis more robust when we omitted the two patients with acute is an accurate predictor of renal function, even for priinterstitial nephritis, who had a high proliferative activity mary glomerular diseases [29] . One of the most perof infiltrating mononuclear cells but a low level interstiplexing features of renal fibrogenesis is the fact that tial FGF-2 staining. In that case (N ϭ 30), correlation fibrosis often progresses despite resolution of the priof FGF-2 staining with MIB-1-positive interstitial cells mary inflammatory stimulus [40] . Thus, we and others (r ϭ 0.71, P Ͻ 0.01) and tubular cells (r ϭ 0.66, P Ͻ have propagated the existence of autocrine cytokine 0.01) was much better. The results are displayed in Figure  loops , which may represent one of the key differences 11. Thus, the results of the MIB-1 staining demonstrate between regular wound healing and scarring [41] [42] [43] . that FGF-2 positivity is correlated positively with the The current studies that combined descriptional and number of MIB-1-positive cells within the interstitium functional analyses were undertaken to elucidate the and in tubular epithelia in scarring processes. This was role of FGF-2 in renal fibrogenesis. We have carefully even true when glomerular diseases were analyzed sepaanalyzed the usefulness of the antibody used in our study rately with a positive correlation between FGF-2 staining given the controversial information regarding the detecand interstitial MIB-1 positivity (r ϭ 0.64, P Ͻ 0.05), tion of FGF-2. Different splice variants may be the reason that a variety of studies came to different conclusions although the number of analyzed tissues was small (N ϭ regarding the localization of FGF-2. As was shown in sections also synthesize FGF-2 mRNA. In addition, we have demonstrated for the first time that the expression the medullary Tk 173 and Tk 188 fibroblasts, the Ab-2 antibody mainly detects the 18 kD band, but also the of FGF-2 protein and mRNA is increased in kidneys with tubulointerstitial scarring, irrespective of the pri-22.5 and 24 kD bands described previously [35] . These higher molecular weight forms may target intracellular mary disease. Furthermore, our study has shown that primary cortical fibroblasts express FGF-2 and one of FGF-2 to a nuclear localization [44] ; however, their exact role is currently unclear. The higher molecular weight its high-affinity receptors. FGF-2 causes a robust induction in proliferation in these cells and induces ␣-smooth forms could not be detected in our primary cortical fibroblasts. Thus, the 18 kD band seems to be the dominating muscle actin expression as marker for myofibroblast formation but has no major effect on synthesis of collagen isoform in kidney fibroblasts.
Our study demonstrates that FGF-2 protein can be type I and fibronectin. Proliferative activity in tubular epithelial and interstitial cells is increased in diseased detected in glomerular, vascular, a few (mainly distal) tubular, as well as interstitial fibroblast-like cells in norhuman kidneys and correlates with staining for FGF-2. Finally, basal proliferation in cortical fibroblasts can be mal human kidneys. In cryosections, more interstitial cells were labeled than in paraffin-embedded tissue secreduced by the addition of a neutralizing antibody to FGF-2, pointing to a possible autocrine mechanism of tions, which may explain the differences to the study by Floege et al, who described only occasional interstitial fibroblast proliferation. Thus, our study provides evidence for the existence of an autocrine loop in human cell positivity [18] . The in situ hybridizations confirmed that the same cells that stain positive for FGF-2 in cyrorenal fibrogenesis, which is characterized by constitutive knockout mice display delayed wound healing [47] , further pointing to a critical role for the cytokine in matrix formation. Unlike most other polypeptide growth factors, FGF-2 lacks a conventional leader sequence for secretion, and the mechanisms for its release are still unclear [11] . Chronically injured cells, however, release FGF-2 efficiently, and the mitogenic effect of the cytokine is potentiated by tissue injury [48] . In addition, as was originally shown by Mignatti, Morimoto, and Rifkin, FGF-2 may be secreted by viable cells [49] .
What is the role of proliferation in renal fibrogenesis? Proliferation was thought to play only a little role, if at all, in the progression of renal disease. However, as was demonstrated by Nadasdy et al in a study of 28 human end-stage kidneys, even scarred kidneys display high proliferative activity in tubuli and interstitial cells [50] . Similar results were recently described by Thomas et al in the subtotal nephrectomy model of chronic renal failure [51] . These findings are corroborated by our study. It is intriguing to speculate that fibroblasts and tubular epithelial cells stimulate each other in the process of renal fibrogenesis, as indicated by the paralleled proliferation. We and others have recently demonstrated that tubular epithelial cells may acquire certain characteristics of fibroblasts [27, 52]. Although we did not examine this aspect in the current study, FGF-2 may be a candidate cytokine that could play a role in that process. Clearly, the interaction between tubular epithelial cells and fibroblasts plays a role not only in the initiation of interstitial inflammation, but also in progressive renal scarring. In the study by Ray et al in their transgenic mouse model of HIV-associated nephropathy, FGF-2 detection was associated with interstitial areas that con- 
Autocrine stimulation of cell proliferation caused by
The r depicts the value for Spearman's rank order coefficient.
FGF-2 has been described in a number of cells, including tubular epithelial [43] , endothelial [53] , and vascular smooth muscle [54] cells. In these cell types, as in cortical expression of FGF-2 and its receptors, up-regulation in fibroblasts, the efficacy of the neutralizing antibody indidisease state, induction of proliferation, and decreased cates that the protein does get secreted before binding proliferation after neutralization of the cytokine.
to its receptors. The increased expression of FGF-2 in renal fibrogenBasic fibroblast growth factor exerts its effects via lowesis, although demonstrated for the first time, is not surand four high-affinity receptors. The high-affinity recepprising. The association of FGF-2 expression with proliftors consist of four transmembrane tyrosine kinases erative fibrogenesis was first demonstrated by Gonzalez (FGFR-1 to -4) [11] . Our study has demonstrated that et al in patients with Dupuytren's contracture [45] . They primary cortical fibroblasts express FGFR-1, also known noted already intense staining for FGF-2 associated with as flg, and heparan sulfate proteoglycan, which potentiincreased synthesis for FGF-2 and FGFR-1 mRNA in ates the binding to the high-affinity receptors [55] . Floege fibroblasts. Charlotte et al found increased expression et al noted occasional interstitial staining for flg [18] . In of FGF-2 in the carbon tetrachloride model of rat liver our study, only three of the five examined fibroblast lines fibrosis [46] . In that study, FGF-2 expression was localfrom kidneys with interstitial fibrosis displayed an upregulated expression for FGFR-1. One possible explanaized to myofibroblastic liver cells. Interestingly, FGF-2 tion is the redundancy of the fibroblast receptor system, relating with the degree of interstitial injury. Morita et including multiple splice variants. In a recent study by al examined the expression of FGF-2 binding domains Ford et al, all seven receptor isoforms assayed by the in human kidneys. FGF-2 binding heparan sulfate dogroup were expressed in whole cortex by reverse tranmains are present in the basement membrane proteoglyscription-polymerase chain reaction assay [56] . Thus, incan perlecan, but are absent from other glycosaminoglycreased expression of one of the other high-affinity recans such as fibroglycan and glypican [64] . Heparan ceptors may explain the lack of up-regulation of FGFR-1 sulfate was detected in sections with glomerular sclerosis in two kidneys with interstitial scarring. Alternatively, and interstitial fibrosis; however, only the fibrotic secdown-regulation of FGFR-1 during a late stage of fibrotions contained FGF-2 binding [65] . Interestingly, a small genesis may protect the kidney from uncontrolled prolifpopulation of macrophage-like parenchymal cells was eration. The mechanism of overexpression of FGF-2 and identified in that study which expressed the FGF-2-FGFR-1 has been described in certain tumor cells, inbinding domain on the cell surface, which is in concorcluding human hepatoma cells [57] .
dance with the results of our study. Heparan sulfate proteoglycan is a low-affinity receptor No significant effect of FGF-2 on synthesis of matrix for FGF-2. Its expression in all seven primary cortical components was observed in our study, although there fibroblasts may explain why heparin (which otherwise is was a tendency for decreased synthesis of collagen type I. known to increase the proliferative effects of FGF-2)
Decreased synthesis of collagen type I in cells of mesendid not have any additional effects on proliferation. Conchymal origin after incubation with FGF-2 has been deversely, the slight reduction in proliferation caused by scribed before. Tan et al, for example, demonstrated a heparin itself may be explained by competition with this down-regulation of collagen gene expression in keloid low-affinity receptor [58] .
fibroblasts [66] . Thus, unlike TGF-␤1, a role of FGF-2 Our findings of FGF-2 and FGFR-1 detection in huin the accumulation of extracellular matrix is not supman kidney fibroblasts or fibroblast-like cells are in conported by our study nor by the literature. However, cordance with observations by other groups in dermal FGF-2 does induce expression of ␣-smooth muscle actin [59], mammary gland [60] , and human liver [61] fibroas an indicator of myofibroblast formation. In that reblasts. However, we extend those findings, demonstragard, it is similar to TGF-␤1, which is the prototype of ting that renal fibroblasts (or fibroblast-like cells) do a profibrogenic cytokine in the kidney. Expression of express FGF-2 in vivo as well. The interstitial cells that ␣-smooth muscle actin has been correlated with interstiexpress FGF-2 are predominantly renal fibroblast-like tial matrix formation and even with prognosis in a numcells as shown by double labelings. Vimentin, ␣-smooth ber of studies in the kidney [67] and other organs [68] . muscle actin, CD 44, and CD 54 are all markers for It certainly represents a critical step in fibrogenesis [69] . fibroblasts in the kidney [36, 37] . However, though alIn summary, we have demonstrated that FGF-2 is exmost all CD 44-and CD 54-positive cells within the pressed in interstitial fibroblast-like cells and that it is interstitium expressed FGF-2, some interstitial cells disrobustly up-regulated within these and tubular epithelial played exclusive FGF-2 positivity. In addition, a number cells in human kidney fibrosis. Whereas FGF-2 does not of ␣-smooth muscle actin-positive cells were negative for seem to play a role in interstitial matrix production, it FGF-2. Renal interstitial fibroblasts are a heterogeneous may have a critical role in fibroblast proliferation and population [62] , and studies on these cells are still hammyofibroblast formation. The continuity of fibroblast pered by the lack of a definite fibroblast marker [1] . Most proliferation is probably one of the major differences of these cells seem to express FGF-2 in vivo, although between fibrosis and restitutional healing. Our study some subpopulations may not. Conversely, some nonfipoints to an important role of FGF-2 in that process. broblast cells such as monocytes/macrophages or denClearly, further studies are necessary that delineate the dritic cells express FGF-2, although the majority of these differences between regular wound healing with no or cells do not under normal conditions. minor scar formation and interstitial fibrosis resulting in Previous studies suggested that extrarenal sources may progressive loss of organ function. contribute to FGF-2 deposition in the kidney [25] . Although we cannot completely exclude that possibility, it ACKNOWLEDGMENTS seems unlikely given the marked up-regulation of FGF-2
This work was supported in part by grants from the Deutsche mRNA synthesis in fibrotic kidneys, as demonstrated by glomeruli and in areas of tubulointerstitial damage, cor-
